CXR/MRI† (localized as baseline) | | | |
Locally advanced | 1.5 | 0.8–2.5 | 0.19 |
Metastatic | 2.2 | 0.9–5.2 | 0.08 |
CCT*/MRI† (localized as baseline) | | | |
Locally advanced | 1.5 | 0.8–3.0 | 0.22 |
Metastatic | 1.2 | 0.6–2.5 | 0.58 |
PET/CT (localized as baseline) | | | |
Locally advanced | 4.6 | 1.4–15.4 | 0.01 |
Metastatic | 17.0 | 5.2–56.1 | <0.001 |